Article

Hydroxychloroquine and mortality risk of patients with COVID-19: a systematic review and meta-analysis of human comparative studies

2020-06-19

Abstract excerpt

<h4>Background</h4> Global COVID-19 deaths reached at least 400,000 fatalities. Hydroxychloroquine is an antimalarial drug that elicit immunomodulatory effects and had shown in vitro antiviral effects against SRAS-CoV-2. This drug divided opinion worldwide in the medical community but also in the press, the general public and in public health policies. The aim of this systematic review and this meta-analysis was t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5dd01e37-8f93-5ee4-bf8a-1f7ec97b12f6
DOI: 10.1101/2020.06.17.20133884

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Hydroxychloroquine and mortality risk of patients with COVID-19: a systematic review and meta-analysis of human comparative studiesDOI 10.1101/2020.06.17.20133884Read

Low dose hydroxychloroquine is associated with lower mortality in COVID-19: a meta-analysis of 26 studies and 44,521 patientsSemantic proximity Read

Low Dose Hydroxychloroquine is Associated with Lower Mortality in COVID-19: A Meta-Analysis of 27 Studies and 44,684 PatientsSemantic proximity Read

HYDROXYCHLOROQUINE FOR THE TREATMENT OF SEVERE RESPIRATORY INFECTION BY COVID-19: A RANDOMIZED CONTROLLED TRIALSemantic proximity Read

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trialsSemantic proximity Read

Disentangling the association of hydroxychloroquine treatment with mortality in Covid-19 hospitalized patients through Hierarchical ClusteringSemantic proximity Read

Hydroxychloroquine with or Without Azithromycin for Treatment of Early SARS-CoV-2 Infection Among High-Risk Outpatient Adults: A Randomized Clinical TrialSemantic proximity Read

Pooled evidence precision of clinical trials on hydroxychloroquine for Covid-19 treatment was stabilized eight months after the outbreakSemantic proximity Read

Hydroxychloroquine/Chloroquine in COVID-19 With Focus on Hospitalized Patients – A Systematic ReviewSemantic proximity Read

Hydroxychloroquine and azithromycin: As a double edge sword for COVID-19?Semantic proximity Read

Efficacy and safety outcomes in randomized controlled trials investigating hydroxychloroquine for COVID-19Semantic proximity Read

Hydroxychloroquine for prevention of COVID-19 mortality: a population-based cohort studySemantic proximity Read

Preventing disease after exposure to COVID-19 using hydroxychloroquine: A summary of a protocol for exploratory re-analysis of age and time-nuanced effectsSemantic proximity Read